This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Fridaybenzinga_article·1 day ago, 08:29 AMSTTK+4.80%SUN+0.83%
Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at JPMorgan Chase & Co.Market Beat·1 day ago, 07:06 AMSTTK+4.80%
Shattuck Labs posts corporate presentation outlining DR3 antibody program for inflammatory diseasesPUBT·Jul 14 at 07:50 AMSTTK+4.80%
STTK: Lead DR3 antibody SL-325 shows promise for IBD with strong safety and low immunogenicityQuartr·Jul 14 at 07:45 AMSTTK+4.80%
Shattuck Labs CTO Abhinav A. Shukla sells 410 common shares worth $2,874.1PUBT·Jul 7 at 06:00 PMSTTK+4.80%
Shattuck Labs CMO Arundathy N. Pandite sells 30,000 shares for $210,300PUBT·Jul 2 at 07:15 PMSTTK+4.80%
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watchrttnews·Jun 14 at 09:09 PMALMS-1.06%TXMD0.00%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jun 12 at 12:05 PMCUPR+0.76%AIM-0.40%
Shattuck Labs Prices Upsized Public Equity and Warrant OfferingTip Ranks·Jun 11 at 07:45 AMSTTK+4.80%
Shattuck Labs Announces Pricing Of 10.88 Mln Shares Public Offering At $4/Shrrttnews·Jun 10 at 12:39 AMSTTK+4.80%
Shattuck Labs, Inc. Announces Proposed Public Offering | STTK Stock NewsStockTitan·Jun 9 at 07:18 AMSTTK+4.80%PIPR+0.37%